(Q26823403)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Epigenomics of leukemia: from mechanisms to therapeutic applications (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Michael Schnekenburger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marc Diederich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Cristina Florean

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Cindy Grandjenette

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mario Dicato

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

1 reference

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

581-609

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization

17 January 2020

cites work

1 reference

Gene expression profiling in chronic lymphocytic leukaemia

21 January 2018

1 reference

21 January 2018

Molecular basis of CLL

1 reference

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up

21 January 2018

1 reference

Critical molecular pathways in cancer stem cells of chronic myeloid leukemia

21 January 2018

1 reference

The molecular signature of oncofusion proteins in acute myeloid leukemia.

21 January 2018

1 reference

Epigenetic aberrations during oncogenesis.

21 January 2018

1 reference

The fundamental role of epigenetics in hematopoietic malignancies

21 January 2018

1 reference

Leukaemogenesis: more than mutant genes

21 January 2018

1 reference

The epigenomics of cancer

21 January 2018

1 reference

The cancer epigenome--components and functional correlates

21 January 2018

1 reference

Epigenetic gene silencing in cancer: the DNA hypermethylome

21 January 2018

1 reference

Epigenetic modifications and human disease

21 January 2018

1 reference

Developmental programming of CpG island methylation profiles in the human genome

21 January 2018

1 reference

X-changing information on X inactivation

21 January 2018

1 reference

Genomic imprinting and methylation: epigenetic canalization and conflict

21 January 2018

1 reference

Retrotransposons Revisited: The Restraint and Rehabilitation of Parasites

21 January 2018

1 reference

The complex language of chromatin regulation during transcription

21 January 2018

1 reference

Chromatin modifications and their function

21 January 2018

1 reference

DNA methylation and gene silencing in cancer

21 January 2018

1 reference

Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.

21 January 2018

1 reference

Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia.

21 January 2018

1 reference

5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia

21 January 2018

1 reference

Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia

21 January 2018

1 reference

Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL

21 January 2018

1 reference

Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia

21 January 2018

1 reference

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

21 January 2018

1 reference

Genetics and molecular biology of chronic lymphocytic leukemia

21 January 2018

1 reference

DNA methylation changes in leukaemia

21 January 2018

1 reference

Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia

21 January 2018

1 reference

Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia

21 January 2018

1 reference

Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia

21 January 2018

1 reference

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

Array-based genomic resequencing of human leukemia

21 January 2018

1 reference

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

Epigenetic modifiers: basic understanding and clinical development.

21 January 2018

1 reference

Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

21 January 2018

1 reference

Hypomethylation and apoptosis in 5-azacytidine-treated myeloid cells

21 January 2018

1 reference

Sustained exposure to the DNA demethylating agent, 2'-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy

21 January 2018

1 reference

The diverse functions of histone lysine methylation

21 January 2018

1 reference

Acetylation of proteins as novel target for antitumor therapy: review article.

21 January 2018

1 reference

Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design

21 January 2018

1 reference

The emerging role of lysine acetylation of non-nuclear proteins

21 January 2018

1 reference

Histone deacetylases--an important class of cellular regulators with a variety of functions

21 January 2018

1 reference

Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

21 January 2018

1 reference

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

21 January 2018

1 reference

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

21 January 2018

1 reference

Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.

21 January 2018

1 reference

PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.

21 January 2018

1 reference

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

21 January 2018

1 reference

Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

21 January 2018

1 reference

Chromatin modifying activity of leukaemia associated fusion proteins

21 January 2018

1 reference

Chromatin remodeling and cancer, Part I: Covalent histone modifications

21 January 2018

1 reference

CREBBP mutations in relapsed acute lymphoblastic leukaemia

21 January 2018

1 reference

Protein methyltransferases as a target class for drug discovery

21 January 2018

1 reference

Histone demethylation by a family of JmjC domain-containing proteins

21 January 2018

1 reference

Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease

21 January 2018

1 reference

Mechanisms of transcriptional repression by histone lysine methylation

21 January 2018

1 reference

Cancer genetics of epigenetic genes

21 January 2018

1 reference

Histone methyltransferases in cancer

21 January 2018

1 reference

MLL: a histone methyltransferase disrupted in leukemia

21 January 2018

1 reference

hDOT1L links histone methylation to leukemogenesis

21 January 2018

1 reference

H3K79 methylation profiles define murine and human MLL-AF4 leukemias

21 January 2018

1 reference

Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes

21 January 2018

1 reference

NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

21 January 2018

1 reference

NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

21 January 2018

1 reference

Roles of the EZH2 histone methyltransferase in cancer epigenetics

21 January 2018

1 reference

Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy

21 January 2018

1 reference

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

21 January 2018

1 reference

Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males

21 January 2018

1 reference

KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia

21 January 2018

1 reference

LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis

21 January 2018

1 reference

Acute myeloid leukemia: therapeutic impact of epigenetic drugs

21 January 2018

1 reference

Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions

21 January 2018

1 reference

Clinical studies of histone deacetylase inhibitors.

21 January 2018

1 reference

Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia

21 January 2018

1 reference

Targeting histone deacetyalses in the treatment of B- and T-cell malignancies

21 January 2018

1 reference

Histone deacetylases and epigenetic therapies of hematological malignancies

21 January 2018

1 reference

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines

21 January 2018

1 reference

Risk of aplastic anemia in patients using antiepileptic drugs

21 January 2018

1 reference

Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway

21 January 2018

1 reference

Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells

21 January 2018

1 reference

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

21 January 2018

1 reference

Tuning acetylated chromatin with HAT inhibitors: a novel tool for therapy

21 January 2018

1 reference

Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor

21 January 2018

1 reference

HAT trick: p300, small molecule, inhibitor

21 January 2018

1 reference

Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9.

21 January 2018

1 reference

Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.

21 January 2018

1 reference

Total synthesis of (+)-chaetocin and its analogues: their histone methyltransferase G9a inhibitory activity

21 January 2018

1 reference

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition

21 January 2018

1 reference

Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase

21 January 2018

1 reference

Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294

21 January 2018

1 reference

Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases

21 January 2018

1 reference

Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a

21 January 2018

1 reference

Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines

21 January 2018

1 reference

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

21 January 2018

1 reference

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

21 January 2018

1 reference

Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications

21 January 2018

1 reference

trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.

21 January 2018

1 reference

Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1

21 January 2018

1 reference

Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2

21 January 2018

1 reference

Mechanistic analysis of a suicide inactivator of histone demethylase LSD1

21 January 2018

1 reference

Identification of cell-active lysine specific demethylase 1-selective inhibitors

21 January 2018

1 reference

(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators

21 January 2018

1 reference

Structural insights into histone lysine demethylation

21 January 2018

1 reference

Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors.

21 January 2018

1 reference

Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors

21 January 2018

1 reference

Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches

21 January 2018

1 reference

MicroRNA biogenesis and cancer

21 January 2018

1 reference

microRNAs in cancer: from bench to bedside

21 January 2018

1 reference

The diverse functions of microRNAs in animal development and disease

21 January 2018

1 reference

The functions of animal microRNAs

21 January 2018

1 reference

MicroRNAs and cancer: profile, profile, profile

21 January 2018

1 reference

MicroRNA and leukemia: tiny molecule, great function

21 January 2018

1 reference

The role of microRNAs in normal and malignant hematopoiesis

21 January 2018

1 reference

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

21 January 2018

1 reference

Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.

21 January 2018

1 reference

Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia

21 January 2018

1 reference

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.

21 January 2018

1 reference

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

21 January 2018

1 reference

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

21 January 2018

1 reference

microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

21 January 2018

1 reference

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

21 January 2018

1 reference

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

21 January 2018

1 reference

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

21 January 2018

1 reference

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

21 January 2018

1 reference

Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.

21 January 2018

1 reference

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

21 January 2018

1 reference

Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits

21 January 2018

1 reference

C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations

21 January 2018

1 reference

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

21 January 2018

1 reference

MicroRNA expression in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.

21 January 2018

1 reference

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

21 January 2018

1 reference

Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.

21 January 2018

1 reference

MicroRNA therapeutics: a new niche for antisense nucleic acids.

21 January 2018

1 reference

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide

21 January 2018

1 reference

miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines

21 January 2018

1 reference

Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells

21 January 2018

1 reference

Epigenetic regulation of microRNAs in acute lymphoblastic leukemia

21 January 2018

1 reference

Cancer chemoprevention by dietary polyphenols: promising role for epigenetics

21 January 2018

1 reference

Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders.

21 January 2018

1 reference

Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia

21 January 2018

1 reference

Large-scale analysis of DNA methylation in chronic lymphocytic leukemia

21 January 2018

1 reference

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia.

21 January 2018

1 reference

The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.

21 January 2018

1 reference

A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers

21 January 2018

1 reference

Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.

21 January 2018

1 reference

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours.

21 January 2018

1 reference

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

21 January 2018

1 reference

Epigenetics of acute lymphocytic leukemia

21 January 2018

1 reference

DNA methylation profiles of lymphoid and hematopoietic malignancies

21 January 2018

1 reference

Methylation status of DDIT3 gene in chronic myeloid leukemia

21 January 2018

1 reference

Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

21 January 2018

1 reference

Promoter CpG methylation of oestrogen receptors in leukaemia

21 January 2018

1 reference

Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia

21 January 2018

1 reference

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

21 January 2018

1 reference

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse

21 January 2018

1 reference

Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

21 January 2018

1 reference

Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia

21 January 2018

1 reference

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias

21 January 2018

1 reference

ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.

21 January 2018

1 reference

Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis

21 January 2018

1 reference

Downregulation of microRNAs-143 and -145 in B-cell malignancies

21 January 2018

1 reference

MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27.

21 January 2018

1 reference

miR-34b/miR-34c: a regulator of TCL1 expression in 11q- chronic lymphocytic leukaemia?

21 January 2018

1 reference

Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth

21 January 2018

1 reference

A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia.

21 January 2018

1 reference

MicroRNA miR-125b causes leukemia

21 January 2018

1 reference

MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia.

21 January 2018

1 reference

miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia

21 January 2018

1 reference

Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia

21 January 2018

1 reference

A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes

21 January 2018

1 reference

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

21 January 2018

1 reference

Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias

21 January 2018

1 reference

Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia

21 January 2018

1 reference

The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression

21 January 2018

1 reference

MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia

21 January 2018

1 reference

Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization

21 January 2018

1 reference

Complete characterization of the microRNAome in a patient with acute myeloid leukemia

21 January 2018

1 reference

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia

21 January 2018

1 reference

The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells.

21 January 2018

1 reference

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.

21 January 2018

1 reference

Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases

21 January 2018

1 reference

Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties

21 January 2018

1 reference

Small molecule modulators of histone acetyltransferase p300.

21 January 2018

1 reference

Characterization of novel inhibitors of histone acetyltransferases.

21 January 2018

1 reference

Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of

21 January 2018

1 reference

Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.

21 January 2018

1 reference

Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon

21 January 2018

1 reference

Quercetin is able to demethylate the p16INK4a gene promoter

21 January 2018

1 reference

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

21 January 2018

1 reference

Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols

21 January 2018

1 reference

Mechanism of p300 specific histone acetyltransferase inhibition by small molecules

21 January 2018

1 reference

Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter

21 January 2018

1 reference

Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine

21 January 2018

1 reference

Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines

21 January 2018

1 reference

Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype

21 January 2018

1 reference

Substrate-specific activation of sirtuins by resveratrol

21 January 2018

1 reference

Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha

21 January 2018

1 reference

SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol

21 January 2018

1 reference

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions

21 January 2018

1 reference

Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation

21 January 2018

1 reference

The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival

21 January 2018

1 reference

Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells

21 January 2018

1 reference

Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.

21 January 2018

1 reference

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer

21 January 2018

1 reference

Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein

21 January 2018

1 reference

Modulation of gene methylation by genistein or lycopene in breast cancer cells

21 January 2018

1 reference

Curcumin is a potent DNA hypomethylation agent

21 January 2018

1 reference

Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells

21 January 2018

1 reference

Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.

21 January 2018

1 reference

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

21 January 2018

1 reference

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

21 January 2018

1 reference

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

21 January 2018

1 reference

Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia

21 January 2018

1 reference

7 January 2021

Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia

1 reference

7 January 2021

TCL1 is activated by chromosomal rearrangement or by hypomethylation

1 reference

7 January 2021

MicroRNA biogenesis and cancer

1 reference

7 January 2021

Increasing methylation of the calcitonin gene during disease progression in sequential samples from CML patients

1 reference

7 January 2021

Cytogenetics and molecular genetics of acute lymphoblastic leukemia

1 reference

7 January 2021

Chromatin compaction at Hox loci: a polycomb tale beyond histone tails

1 reference

7 January 2021

CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

1 reference

7 January 2021

Research recommendations toward a better understanding of the causes of childhood leukemia.

1 reference

7 January 2021

DNMT3A mutations in acute myeloid leukemia

1 reference

7 January 2021

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

1 reference

7 January 2021

ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL

1 reference

7 January 2021

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms

1 reference

7 January 2021

MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis

1 reference

7 January 2021

Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia

1 reference

7 January 2021

Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene

1 reference

7 January 2021

Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome

1 reference

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

7 January 2021

Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells

1 reference

7 January 2021

Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter

1 reference

7 January 2021

Identification of acute myeloid leukaemia associated microRNA expression patterns

1 reference

7 January 2021

New prognostic markers in CLL.

1 reference

7 January 2021

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

1 reference

7 January 2021

miR-34a as part of the resistance network in chronic lymphocytic leukemia

1 reference

7 January 2021

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia

1 reference

7 January 2021

Curcumin is an inhibitor of p300 histone acetylatransferase

1 reference

7 January 2021

MicroRNA biogenesis, functionality and cancer relevance.

1 reference

7 January 2021

Identifiers

DOI

10.2217/EPI.11.73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126248%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2 references